POM-V Prescription Required Companion Animal

Canaural Ear Drops, Suspension for Dogs and Cats

Active ingredients: Diethanolamine Fusidate, Framycetin Sulphate, Nystatin, Prednisolone

Form

Drops

Species

Cats Dogs

Manufacturer

Dechra Veterinary Products A/S

VMD MA No.

24883/4004

What it's used for

For the treatment of otitis externa including the ear mite, Otodectes cynotis, infestation in the dog and cat.

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Diethanolamine Fusidate + Fr...

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Canaural Ear Drops, Suspension for Dogs and Cats — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 18 Mar 2026.

For the treatment of otitis externa including the ear mite, Otodectes cynotis,
infestation in the dog and cat.

Where appropriate, prior to administration, the ear canal and the surrounding

Revised: September 2012
AN: 00364/2012
area should be cleaned mechanically or by irrigation taking care to avoid
further damage to the skin. Any excess exudate, hair or debris should be
carefully removed prior to the application of the ear drops. Animal owners
should only do this on the direction of the prescribing veterinary surgeon.
Shake the bottle well before use.
Instil 5-10 drops into the ear according to the size of the animal and ear canal
twice daily.
Without allowing the animal to shake its head, very gently massage the ear
canal after administration holding the pinna in an upright position to ensure
penetration of the drops into the ear.
Where ear mite infection is present, consideration should be given to treating
both ears, even if infection is apparent in only one. Treatment should continue
for at least 3 weeks to ensure that successive generations of ear mites are
killed. Animals that are in contact should also be treated.
Where treatment is for a period longer than 7 days regular clinical re-
evaluation should be carried out.
Where Gram-negative infections are involved, the use of the veterinary
medicinal product should be based on bacterial sensitivity testing. In cases
where the treatment period is prolonged, in vitro sensitivity should be re-
evaluated.

Do not use in animals with a perforated eardrum.
Do not use concomitantly with products known to be ototoxic.
Do not use in animals with known hypersensitivity to the active substances or
to the excipient.

On very rare occasions and primarily in geriatric animals, use of auricular
preparations may be associated with hearing impairment which may be either
transient or prolonged.
Allergy or hypersensitivity reactions to the active substances or the excipient
might occur.
Anti-inflammatory corticosteroids such as Prednisolone can exert a wide
range of side effects. Dosage in medium to long term use should therefore
generally be kept to the minimum.
During therapy effective doses suppress the hypothalamic-pituitreal adrenal
axis. Following cessation of treatment symptoms of adrenal insufficiency can
arise and this may render the animal unable to deal adequately with stressful
situations.
Corticosteroids may delay wound healing and the immunosuppressant actions
may weaken resistance to, or exacerbate existing infections.

For external use only.
To be used under veterinary supervision.

Revised: September 2012
AN: 00364/2012

Official, national and regional antimicrobial policies should be taken into
account when the product is used.
i. Special precautions for use in animals
Following recovery the ears should be checked at regular intervals for
any signs of re-infection.
ii. Special precautions to be taken by the person administering the
veterinary medicinal product to animals
Avoid contact with the product.
Wash hands after use.
If the product comes into contact with the eyes, rinse immediately with
plenty of water.
People with known hypersensitivity to any of the active substances or
the excipient in the product should avoid contact with the veterinary
medicinal product.

None known.

Revised: September 2012
AN: 00364/2012
Do not store above 25C.
Protect from direct sunlight.
Keep the bottle in the outer carton.

Framycetin sulphate 5.0 mg
Nystatin 100,000 IU
Prednisolone 2.5 mg
Excipient:
For a full list of excipients, see section

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.